Skip to content

Effect of lidocaine gel on pain from copper IUD insertion: A randomized controlled trial

Effect of lidocaine gel on pain from copper IUD insertion: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138903093706N3
Enrollment
96
Registered
2010-09-21
Start date
2010-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain from copper IUD insertion. Insertion of (intrauterine) contraceptive device

Interventions

Intervention 1: Group 3 will get no intervention. Intervention 2: Group 1: lidocaine 2% gel will be placed in the cervical canal by a sterile swab one minute before IUD insertion. Intervention 3: Gro
Prevention
Group 3 will get no intervention.
Group 1: lidocaine 2% gel will be placed in the cervical canal by a sterile swab one minute before IUD insertion
Group 2: lubricant gel will be placed in the cervical canal by a sterile swab one minute before IUD insertion.

Sponsors

Research Deputy of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 48 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: All IUD clients of Bavafa health center who have no IUD contraindication, including: Pregnancy, puerprium sepsis, pelvic inflammatory disease or sexually transmitted infections (currently or in past 3 months), known or suspected uterine or cervical cancer, unknown genital abnormal bleeding, uterine fibroids and tumors causing deformity in uterus. Exclusion criteria: any problem during IUD insertion for any reason; in this case another gel with the same number will be replaced.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain severity. Timepoint: Immediately after IUD insertion. Method of measurement: 10 cm visual analog scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarideh Kazemi

Tabriz university of medical sciences

f.kazemi21@gmail.com+98 81 1254 9670

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026